With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Medspas are leading the charge in offering GLP-1 treatments, with 60% of medspas in the U.S. now providing these services, compared to 35% of aesthetic physician offices. Average spend per patient ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from ... For complete results, see Which State Medicaid Programs Cover GLP-1s for Weight Loss & How Much Are They ...

A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar weight-loss drugs as ... like Ozempic, is a GLP-1 inhibitor – a class ...

A growing number of young people are receiving prescriptions for GLP-1 weight loss medications like Ozempic and Wegovy. Janet Shamlian examines why. A doctor who says he's reversed his age by 20 ...

A growing number of young people are receiving prescriptions for GLP-1 weight loss medications like Ozempic and Wegovy. Janet Shamlian examines why. Miami Star Cam Ward Made a Business Decision at ...

In January 2020, spending on Ozempic, a Type 2 diabetes-indicated GLP-1, was just $4.6 million, while Wegovy—one of the most prominent FDA-approved GLP-1s for weight management—had not yet ...